Proposed Data Collection Submitted for Public Comment and Recommendations, 19306-19307 [2023-06734]
Download as PDF
<![CDATA[
19306
Federal Register / Vol. 88, No. 62 / Friday, March 31, 2023 / Notices
have been placed in liquidation, please
contact the Chief, Receivership
Oversight at RO@fdic.gov or at Division
of Resolutions and Receiverships, FDIC,
600 North Pearl Street, Suite 700,
Dallas, TX 75201.
INSTITUTIONS IN LIQUIDATION
[In alphabetical order]
FDIC ref. No.
Bank name
City
10541 ..............
10542 ..............
Signature Bridge Bank, N.A ........................................................
Silicon Valley Bridge Bank, N.A .................................................
New York ..................................
Santa Clara ..............................
Federal Deposit Insurance Corporation.
Dated at Washington, DC, on March 27,
2023.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2023–06660 Filed 3–30–23; 8:45 am]
BILLING CODE 6714–01–P
FEDERAL RESERVE SYSTEM
ddrumheller on DSK120RN23PROD with NOTICES1
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than April 17, 2023.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, IL 60604.
1. The Kehl Family 2009 Trust; the
Kehl Grandchildren’s Trust dated
November 5, 1997; the Kehl
Grandchildren’s Trust fbo Cody J. Kehl
VerDate Sep<11>2014
19:31 Mar 30, 2023
Jkt 259001
dated November 5, 1997; the Ruth A.
Kehl Grandchildren’s Trust fbo Jacob R.
Winter dated November 5, 1997; and the
Ruth A. Kehl Grandchildren’s Trust fbo
Tanner C. Kehl dated November 5, 1997,
The First National Bank in Sioux Falls,
as trustee of the aforementioned trusts,
all of Sioux Falls, South Dakota; The
Kevin A. Kehl Trust May 15, 2017, Kevin
A. Kehl, as trustee, Dubuque, Iowa; and
Krystina L. Moore, Tiffin, Iowa; to join
the Kehl Family Control Group, a group
acting in concert, to acquire voting
shares of Savanna-Thomson Investment,
Inc., Savanna, Illinois, and thereby
indirectly acquire voting shares of
Savanna-Thomson State Bank, Thomas,
Illinois.
Additionally, Daniel J. Kehl, Solon,
Iowa, to join the Kehl Family Control
Group, to retain voting shares of
Savanna-Thomson Investment, Inc., and
thereby indirectly acquire voting shares
of Savanna-Thomson State Bank.
Board of Governors of the Federal Reserve
System.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2023–06752 Filed 3–30–23; 8:45 am]
BILLING CODE P
GENERAL SERVICES
ADMINISTRATION
[OMB Control No. 3090–XXXX; Docket No.
2022–0001; Sequence No. 16]
GSA Equity Study on Remote Identity
Proofing; Correction
Correction
In the FR Doc. 2023–06174, appearing
on page 18139, in the issue of Monday,
March 27, 2023, make the following
correction:
On page 18139, in the second column,
in the SUPPLEMENTARY INFORMATION
section, ‘‘FR Doc. 2023–03131’’ should
read ‘‘FR Doc. 2023–02918’’.
Lois Mandell,
Director, Regulatory Secretariat Division.
[FR Doc. 2023–06711 Filed 3–30–23; 8:45 am]
BILLING CODE 6820–34–P
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
State
NY
CA
Date closed
03/20/2023
03/27/2023
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–1308; Docket No. CDC–2023–
0021]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Validated
Follow-up Interview of Clinicians on
Outpatient Antibiotic Stewardship
Interventions. This collection aims to
perform an interview of outpatient
clinicians regarding the acceptability
and perceived clinician-level barriers
associated with our year-long
implementation of interventions
designed around the Core Elements of
Outpatient Antibiotic Stewardship.
DATES: CDC must receive written
comments on or before May 30, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2023–
0021 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
SUMMARY:
E:\FR\FM\31MRN1.SGM
31MRN1
19307
Federal Register / Vol. 88, No. 62 / Friday, March 31, 2023 / Notices
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
which is an urgent national and global
health threat. Additionally,
inappropriate antibiotic prescribing
contributes to avoidable adverse drug
events that cause substantial harms to
patients. Most antibiotic prescribing
originates in traditional outpatient
settings such as physician offices and
emergency departments, and at least
30% of these prescriptions are
completely unnecessary.
Over the past decade there has been
rapid growth in non-traditional
outpatient settings including Urgent
Care clinics. Recent evidence shows that
when compared to traditional office
settings, inappropriate antibiotic
prescribing is substantially higher in
Urgent Care clinics making this an
important priority for antibiotic
stewardship. The design, development,
and evaluation of durable stewardship
interventions addressing the unique
setting of Urgent Care clinics is an
important area of unmet need. This data
collection will assess knowledge,
attitudes, and practices related to
antibiotic prescribing among clinicians
after implementation of a year-long
Urgent Care stewardship initiative.
CDC requests OMB approval for an
estimated 62 annualized burden hours.
There is no cost to respondents other
than their time to participate.
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Validated Interview and Survey of
Outpatient Providers on Antibiotic
Stewardship Interventions (OMB
Control No. 0920–1308)—
Reinstatement—National Center for
Emerging Zoonotic and Infectious
Disease (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Inappropriate antibiotic prescribing is
a major driver of antibiotic resistance
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Total burden
(in hours)
Form name
Urgent Care Clinician ........................
Urgent Care Clinician ........................
Interview Guide ................................
Survey ..............................................
20
125
1
1
1
20/60
20
42
Total ...........................................
...........................................................
........................
........................
........................
62
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–06734 Filed 3–30–23; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
[30Day–23–1215]
Agency Forms Undergoing Paperwork
Reduction Act Review
ddrumheller on DSK120RN23PROD with NOTICES1
Average
burden per
response
(in hours)
Number of
responses per
respondent
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Awardee Lead
Profile Assessment (ALPA)’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
VerDate Sep<11>2014
17:54 Mar 30, 2023
Jkt 259001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on December 20, 2022, to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
E:\FR\FM\31MRN1.SGM
31MRN1
]]>Agencies
[Federal Register Volume 88, Number 62 (Friday, March 31, 2023)]
[Notices]
[Pages 19306-19307]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06734]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-1308; Docket No. CDC-2023-0021]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Validated Follow-up Interview of Clinicians on Outpatient
Antibiotic Stewardship Interventions. This collection aims to perform
an interview of outpatient clinicians regarding the acceptability and
perceived clinician-level barriers associated with our year-long
implementation of interventions designed around the Core Elements of
Outpatient Antibiotic Stewardship.
DATES: CDC must receive written comments on or before May 30, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0021 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
[[Page 19307]]
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Validated Interview and Survey of Outpatient Providers on
Antibiotic Stewardship Interventions (OMB Control No. 0920-1308)--
Reinstatement--National Center for Emerging Zoonotic and Infectious
Disease (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Inappropriate antibiotic prescribing is a major driver of
antibiotic resistance which is an urgent national and global health
threat. Additionally, inappropriate antibiotic prescribing contributes
to avoidable adverse drug events that cause substantial harms to
patients. Most antibiotic prescribing originates in traditional
outpatient settings such as physician offices and emergency
departments, and at least 30% of these prescriptions are completely
unnecessary.
Over the past decade there has been rapid growth in non-traditional
outpatient settings including Urgent Care clinics. Recent evidence
shows that when compared to traditional office settings, inappropriate
antibiotic prescribing is substantially higher in Urgent Care clinics
making this an important priority for antibiotic stewardship. The
design, development, and evaluation of durable stewardship
interventions addressing the unique setting of Urgent Care clinics is
an important area of unmet need. This data collection will assess
knowledge, attitudes, and practices related to antibiotic prescribing
among clinicians after implementation of a year-long Urgent Care
stewardship initiative.
CDC requests OMB approval for an estimated 62 annualized burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Urgent Care Clinician......... Interview Guide. 20 1 1 20
Urgent Care Clinician......... Survey.......... 125 1 20/60 42
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 62
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-06734 Filed 3-30-23; 8:45 am]
BILLING CODE 4163-18-P
